Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 3Colorectal Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Melanoma 1Lymphoma 1Head and Neck Neoplasms 1Glioma 1Digestive System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Sunitinib 2Irinotecan 2Ascorbic Acid 2spartalizumab 1linifanib 1genexol-PM 1dostarlimab 1alectinib 1Sorafenib 1Ramucirumab 1NUC-1031 1Methods 1Meditation 1KRN-330 1Gemcitabine 1Flucytosine 1Everolimus 1Educational Status 1Early Intervention, Educational 1Cisplatin 1Body Height 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Digestive System Neoplasms × Flucytosine × Clear all
NCT03724071 2023-06-23

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Transgene

Phase 1/2 Terminated
51 enrolled
Gastrointestinal

Digestive System Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡